Home » Newsletters » BioWorld Science

BioWorld Science

July 18, 2022

View Archived Issues

Novel hemophilia A murine model to test IdeS proteinase efficacy

Coagulant Therapeutics presents preclinical data on CT-001

Sunshine Lake Pharma patents new chymotrypsin inhibitors

Novartis divulges new cGAS inhibitors

Janssen Pharmaceutica presents new Mcl-1 inhibitors

Pfizer describes new IL-2 production inhibitors

Merck & Co. synthesizes orexin OX2 receptor agonists

PCYOX1 identified as new target for antithrombotic therapy

Enterome and Nestle Health Science collaborate to tackle food allergies and IBD

Murine model shows fibrin alpha crosslinking impairment behind thromboembolism

Thrombogenic effects of allosteric SHP2 inhibitor SHP-099

Defective gamma fibrinogen crosslinking exacerbates liver injury

Spread of Y chromosome deficiency in myeloid cells with age promotes cardiac fibrosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...